Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The Europe in-vitro diagnostics market is expected to grow at a CAGR of 4.2% during the forecast period of 2024-2032, driven by the increasing healthcare needs, the rising development of advanced diagnostic technologies, and regulatory improvements in the region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In-vitro diagnostics (IVD) include tests carried out on samples such as blood or tissue taken from the human body. In vitro diagnostics can detect diseases, infections, or other conditions, and can be used to monitor a person’s overall health to help treat, cure, or prevent illnesses. In-vitro means ‘in glass’, indicating that these tests are generally carried out in test tubes and similar equipment, as against in vivo tests, that are performed in the body itself. In-vitro diagnostics may also be employed in precision medicine to determine patients likely to benefit from particular treatments or therapies. These in-vitro diagnostics include next-generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are carried out in a laboratory or other healthcare settings, while others may be conducted by consumers at home. The tests themselves can be conducted on a wide range of instruments, varying from small, handheld tests to more complex laboratory instruments.
The Europe in-vitro diagnostics market is driven by the increasing prevalence of chronic diseases and the growing aging population fuelling the demand for diagnostic tests to monitor and manage various medical conditions. The rising burden of infectious diseases such as influenza, HIV, and the recent COVID-19 pandemic, is contributing to the expansion of the global in-vitro diagnostic market. The growing demand for home-based diagnostic tests, particularly for chronic disease management, is set to elevate the market value. Other factors that influence the market dynamics include increased public health campaigns, the rising adoption of digital health technologies, and growth in strategic collaborations between diagnostic companies.
Introduction of New Regulations and Companies’ Adherence are Expected to Drive Market Growth
In 2021, the European Commission proposed a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation to avoid disruption in the supply of these essential healthcare products. The In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) established a new regulatory framework for in vitro diagnostic medical devices, such as HIV tests, pregnancy tests or SARS-CoV-2 tests. It is suggested that nearly 70% of clinical decisions are made using in-vitro diagnostic medical devices. While the proposal did not modify any requirements of the In Vitro Diagnostic (IVD) Regulation in substance, it altered the transitional provisions to enable the Regulation's progressive rollout. The length of the proposed transition periods depended on device type; higher-risk devices like HIV or hepatitis tests (class D) and particular influenza tests (class C), had a transition period until May 2025 and 2026; lower-risk devices like class B and A sterile devices had a transition period until May 2027.
In 2023, MedTech Europe welcomed the In Vitro Diagnostic Medical Devices Regulation and urged continued work to deploy the new regulatory system. These developments are expected to augment the Europe in-vitro diagnostics market size.
In 2023, Roche reported that the company was on its way to full IVDR compliance having taken all the necessary steps to successfully meet IVDR. The company’s journey started in 2017 with six quality management systems (QMS) and more than 2,500 material numbers to change to the new regulation. In 2020, the company reached important milestones with the designation of its two notified bodies and the first QMS audits passed. At the end of 2021, Roche successfully passed its six QMS audits and received its six IVDR QMS certificates. The proactive approach of several key market players to IVDR compliance coupled with their commitment to ensure product quality and regulatory requirements is poised to fuel market growth.
Growth in Strategic Partnerships to Meet Rising Europe In-vitro Diagnostics Market Demand
In April 2024, Revvity's German-based subsidiary EUROIMMUN (a leading provider of high-quality in-vitro diagnostic products) partnered with ALPCO-GeneProof (a major immunodiagnostics and molecular diagnostics company) to boost the availability of GeneProof PCR kits across the European Union. This collaboration aims to leverage ALPCO-GeneProof's advanced molecular diagnostic technologies and EUROIMMUN's robust distribution network and infrastructure capabilities to expand CE-IVD-certified molecular assay products. According to the agreement, ALPCO-GeneProof will offer 42 molecular diagnostic assays including GeneProof PCR kits with assays for transplant and immunocompromised patients, bloodborne pathogens, and neuroinfections, among others. The rise in such strategic partnerships among prominent diagnostic companies is anticipated to stimulate market growth and innovation.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current scenario in Europe. Some of the notable trends are as follows:
Key Trends | Impact |
Integration of Digital Technologies | The integration of digital health technologies such as telemedicine and remote monitoring is a major market trend that is set to improve the efficiency of diagnostic services. In addition, the increasing use of artificial intelligence (AI) and big data analytics in in-vitro diagnostic solutions is expected to enhance the speed as well as accuracy of test results. |
Rising Innovation in Diagnostic Technologies | The rising development of advanced diagnostic technologies such as next-generation sequencing (NGS), digital PCR, and high-throughput screening are projected to aid the market expansion. Moreover, the adoption of automated systems and robotic technologies in diagnostic laboratories enhances the efficiency and throughput of diagnostic tests and is likely to boost the Europe in-vitro diagnostics market value. |
Growing Demand for Point-of-Care Testing | There is a growing preference for rapid and convenient diagnostics which directly impacts the demand for point-of-care in-vitro diagnostic solutions. Further, the advances in home-based diagnostic tests for infectious disease screening and chronic disease management are expected to bolster the market growth. |
Increased Public Health Campaigns | The market is experiencing increased public health campaigns and educational programs that promote the need for regular health check-ups and screenings. Such preventive care initiatives are set to drive growth and innovation in the market for in-vitro diagnostic tests. |
Market Breakup by Product Type
Market Breakup by Technology
Market Breakup by Therapeutic Area
Market Breakup by End User
Market Breakup by Country
Market Segmentation Based on Product Type is Set to Witness Substantial Growth
Based on the product type, the market is segmented into reagents and kits, instruments, and software and services. Reagents and kits of in-vitro diagnostic tests are experiencing a substantial market demand due to the increasing number of screening procedures and routine diagnostic tests. The segment also benefits from the development of assays that have multiplex testing capabilities and the launch of point-of-care (POC) testing kits for quick diagnosis.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In Europe, the market breakup by country includes the United Kingdom, Germany, France, Italy, and others. The demand for in-vitro diagnostic products is high in the United Kingdom, owing to the presence of a well-developed healthcare system and the increased focus of the government on promoting regular screening initiatives. Germany is also a major market driven by robust research efforts in advancing medical diagnostics and a significant influx of capital to accelerate the growth of personalized medicine and precision diagnostics.
The key features of the market report comprise patent analysis and strategic initiatives by the leading key players. The major companies in the market are as follows:
F. Hoffmann-La Roche Ltd
Swiss multinational holding healthcare company F. Hoffmann-La Roche Ltd has a prominent presence in the market and operates under two divisions: Pharmaceuticals and Diagnostics. One of its key products is the in-vitro immunoassay Elecsys® Anti-SARS-CoV-2 for qualitative detection of antibodies to SARS-CoV-2.
QIAGEN GmbH
Leading provider of sample and assay technologies, QIAGEN GmbH specializes in the field of molecular diagnostics, applied testing, and research. The company is popular for its infectious disease diagnostics platforms including syndromic testing platform QIAstat-Dx®.
BioMérieux, Inc.
In vitro diagnostics provider BioMérieux, Inc. is a multinational biotechnology company headquartered in France. The company is engaged in continuous innovation in the field of infectious disease diagnostics and significantly contributes to the Europe in-vitro diagnostics market growth.
Siemens Healthineers AG
Headquartered in Germany, Siemens Healthineers AG is a Medtech company known for its robust portfolio of in-vitro diagnostic solutions, including laboratory diagnostics and point-of-care tests. The company is focused on exploring AI-powered diagnostic tools and software.
Other key players in the market include ELITechGroup, Oncgnostics GmbH, Abbott Laboratories, Danaher Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Technology |
|
Breakup by Therapeutic Area |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share